Literature DB >> 2884453

Indium-111-labelled granulocyte accumulation in respiratory tract of patients with bronchiectasis.

D C Currie, S H Saverymuttu, A M Peters, S G Needham, P George, D P Dhillon, J P Lavender, P J Cole.   

Abstract

18 patients with severe bronchiectasis and persistent purulent sputum production were investigated, by the use of gamma scans, between acute exacerbations of their symptoms to determine localisation and traffic of 111In-labelled granulocytes in the lungs. Labelled granulocytes appeared in the respiratory tract of 16 patients within 24 h of their injection. Uptake occurred almost exclusively in areas demonstrated by computed tomography (CT) to be bronchiectatic. However, 111In uptake was not demonstrated in 21 of the 55 segments showing bronchiectasis on CT, and these were therefore thought to be not actively inflamed. The whole-body loss of radioactivity up to 4-7 days following injection of the labelled cells ranged from 0 to 53% and correlated with 24 h purulent sputum volume (r = 0.45, p less than 0.01) and with CT extent of moderate and severe bronchiectasis (r = 0.40, p less than 0.05), but not with overall CT extent of bronchiectasis, age, forced expiratory volume in one second, or duration of purulent sputum production in years.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884453     DOI: 10.1016/s0140-6736(87)90647-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  Occult Enterobacter aerogenes pneumonia diagnosed by indium 111-labeled leukocyte scan.

Authors:  D A Holden; J K Stoller
Journal:  West J Med       Date:  1992-01

2.  Effect of bacterial products on neutrophil migration in vitro.

Authors:  G Ras; R Wilson; H Todd; G Taylor; P Cole
Journal:  Thorax       Date:  1990-04       Impact factor: 9.139

3.  Indium-111 labelled granulocyte scanning to detect inflammation in the lungs of patients with chronic sputum expectoration.

Authors:  D C Currie; A M Peters; N D Garbett; P George; B Strickland; J P Lavender; P J Cole
Journal:  Thorax       Date:  1990-07       Impact factor: 9.139

4.  Quantification of disease activity in patients undergoing leucocyte scintigraphy for suspected inflammatory bowel disease.

Authors:  Heok K Cheow; Demetrius D Voutnis; John W Evans; Katy R Szczepura; E Anna Swift; Nicholas J Bird; Prina Ruparelia; Chandra K Solanki; James R Ballinger; Edwin R Chilvers; Stephen J Middleton; A Michael Peters
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-10-29       Impact factor: 9.236

5.  Inhibition of human neutrophil migration in vitro by low-molecular-mass products of nontypeable Haemophilus influenzae.

Authors:  D R Cundell; G W Taylor; K Kanthakumar; M Wilks; S Tabaqchali; E Dorey; J L Devalia; D E Roberts; R J Davies; R Wilson
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

6.  Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress.

Authors:  I Horvath; S Loukides; T Wodehouse; S A Kharitonov; P J Cole; P J Barnes
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

7.  Quantification of neutrophil migration into the lungs of patients with chronic obstructive pulmonary disease.

Authors:  Prina Ruparelia; Katherine R Szczepura; Charlotte Summers; Chandra K Solanki; Kottekkattu Balan; Paul Newbold; Diana Bilton; A Michael Peters; Edwin R Chilvers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-10       Impact factor: 9.236

Review 8.  Cystic fibrosis. 2. Lung injury in cystic fibrosis.

Authors:  J S Elborn; D J Shale
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

9.  Clindamycin, erythromycin, and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pigments with human neutrophils in vitro.

Authors:  G J Ras; R Anderson; G W Taylor; J E Savage; E van Niekerk; G Joone; H J Koornhof; J Saunders; R Wilson; P J Cole
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 10.  The contribution of nuclear medicine to the patient with infection.

Authors:  W Becker
Journal:  Eur J Nucl Med       Date:  1995-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.